P183 IMPACT OF OBESITY ON SHORT- AND INTERMEDIATE-TERM OUTCOMES IN INFLAMMATORY BOWEL DISEASES: POOLED ANALYSIS OF PLACEBO ARMS OF INFLIXIMAB CLINICAL TRIALS

To assess whether obesity may affect natural history of inflammatory bowel diseases (IBD), we conducted an individual participant data (IPD) pooled analysis of placebo arms, using data from clinical trials of infliximab in IBD, using the Yale Open Data Access (YODA) Project.